Effects of Ramipril and Rosiglitazone on Cardiovascular and Renal Outcomes in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: Results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial

Ítems similars

• Trial update: the Diabetes REduction Approaches with ramipril and rosiglitazone Medications (DREAM) trial
  per: G. Gulli
  Publicat: (2013-05-01)
• Incidence of diabetes following ramipril or rosiglitazone withdrawal
  per: Holman, R, et al.
  Publicat: (2011)
• Incidence of diabetes following ramipril or rosiglitazone withdrawal.
  per: Investigators, D
  Publicat: (2011)
• Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
  per: Gerstein, H, et al.
  Publicat: (2006)
• MARRIAGE: A Randomized Trial of Moxonidine Ramipril or in Combination With Ramipril in Overweight Patients With Hypertension and Impaired Fasting Glucose or Diabetes Mellitus. Impact on Blood Pressure, Heart Rate and Metabolic Parameters
  per: Paul Valensi MD, et al.
  Publicat: (2024-06-01)